[CRVS] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
01-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 9.18%
YoY- -8.95%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -8,363 -8,297 -9,236 -10,673 -11,752 -11,580 27,347 -
Tax -100 884 8 -1,604 -1 -3 -143 -21.26%
NP -8,263 -9,181 -9,236 -10,673 -11,752 -11,580 27,347 -
Tax Rate - - - - - - 0.52% -
Total Cost 8,263 9,181 9,236 10,673 11,752 11,580 -27,347 -
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.18 -0.20 -0.20 -0.24 -0.28 -0.34 0.92 -
EPS Diluted -0.18 -0.20 -0.20 -0.24 -0.28 -0.34 0.92 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.